Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
In the latest session, Universal Health Services, Inc (NYSE: UHS) closed at $226.13 down -2.14% from its previous closing price of $231.08. In other words, the price has decreased by -$2.14 from its previous closing price. On the day, 0.76 million shares were traded. UHS stock price reached its highest trading level at $230.57 during the session, while it also had its lowest trading level at $224.64.
Ratios:
For a deeper understanding of Universal Health Services, Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 127.45 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 14.86. For the most recent quarter (mrq), Quick Ratio is recorded 0.96 and its Current Ratio is at 1.03. In the meantime, Its Debt-to-Equity ratio is 0.71 whereas as Long-Term Debt/Eq ratio is at 0.60.
BofA Securities Downgraded its Neutral to Underperform on July 16, 2025, while the target price for the stock was maintained at $185.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 11 ’25 when WARREN NIMETZ bought 3,817 shares for $223.30 per share.
Nimetz Warren J. sold 3,817 shares of UHS for $852,343 on Nov 11 ’25. The Director now owns 8,481 shares after completing the transaction at $223.30 per share. On Oct 29 ’25, another insider, SUSSMAN ELLIOT J MD MBA, who serves as the Director of the company, sold 965 shares for $225.70 each. As a result, the insider received 217,799 and left with 6,113 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UHS now has a Market Capitalization of 14390618112 and an Enterprise Value of 19564265472. As of this moment, Universal’s Price-to-Earnings (P/E) ratio for their current fiscal year is 10.75, and their Forward P/E ratio for the next fiscal year is 9.62. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.65. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.85 while its Price-to-Book (P/B) ratio in mrq is 1.97. Its current Enterprise Value per Revenue stands at 1.151 whereas that against EBITDA is 7.658.
Stock Price History:
The Beta on a monthly basis for UHS is 1.28, which has changed by 0.20542514 over the last 52 weeks, in comparison to a change of 0.13844287 over the same period for the S&P500. Over the past 52 weeks, UHS has reached a high of $246.32, while it has fallen to a 52-week low of $152.33. The 50-Day Moving Average of the stock is 3.20%, while the 200-Day Moving Average is calculated to be 19.39%.
Shares Statistics:
For the past three months, UHS has traded an average of 658.45K shares per day and 645060 over the past ten days. A total of 55.23M shares are outstanding, with a floating share count of 53.70M. Insiders hold about 15.61% of the company’s shares, while institutions hold 83.69% stake in the company. Shares short for UHS as of 1763078400 were 1879417 with a Short Ratio of 2.85, compared to 1760486400 on 1878407. Therefore, it implies a Short% of Shares Outstanding of 1879417 and a Short% of Float of 4.9000002.
Dividends & Splits
According to the company, the forward annual dividend rate for UHS is 0.80, from 0.8 in the trailing year. Against a Trailing Annual Dividend Yield of 0.0034620045. The stock’s 5-year Average Dividend Yield is 0.48. The current Payout Ratio is 4.76% for UHS, which recently paid a dividend on 2025-12-01 with an ex-dividend date of 2025-12-01. Stock splits for the company last occurred on 2009-12-16 when the company split stock in a 2:1 ratio.
Earnings Estimates
At present, 14.0 analysts are actively evaluating the performance of Universal Health Services, Inc (UHS) in the stock market.The consensus estimate for the next quarter is $5.32, with high estimates of $5.96 and low estimates of $4.88.
Analysts are recommending an EPS of between $21.92 and $20.12 for the fiscal current year, implying an average EPS of $21.66. EPS for the following year is $23.49, with 14.0 analysts recommending between $24.83 and $21.54.
Revenue Estimates
A total of 15 analysts believe the company’s revenue will be $4.5B this quarter.It ranges from a high estimate of $4.57B to a low estimate of $4.45B. As of. The current estimate, Universal Health Services, Inc’s year-ago sales were $4.11BFor the next quarter, 15 analysts are estimating revenue of $4.34B. There is a high estimate of $4.43B for the next quarter, whereas the lowest estimate is $4.22B.
A total of 17 analysts have provided revenue estimates for UHS’s current fiscal year. The highest revenue estimate was $17.45B, while the lowest revenue estimate was $17.17B, resulting in an average revenue estimate of $17.37B. In the same quarter a year ago, actual revenue was $15.83BBased on 16 analysts’ estimates, the company’s revenue will be $18.25B in the next fiscal year. The high estimate is $18.68B and the low estimate is $17.88B.
